Table 5 Self-reported or measured weight at 9 to 12 months after termination of the programme (n = 111)
From: Evaluation of pharmacy-led weight management service to minimise the risk of cardiovascular disease
Weight self-reported/measured (kg) after 9–12 months | |
|---|---|
All participants (n = 111) | |
 Mean | 79.275 |
 SD | 16.15 |
 Minimum | 53.5 |
 Maximum | 142.0 |
Males (n = 32) | |
 Mean | 92.747 |
 SD | 17.40 |
 Minimum | 62.0 |
 Maximum | 142.0 |
Females (n = 79) | |
 Mean | 73.818 |
 SD | 11.9613 |
 Minimum | 53.5 |
 Maximum | 109.0 |
Changes in weight (comparison between last visit and follow-up period) | Frequency (n) | Percentage (%) |
|---|---|---|
Weight loss (n = 49) | ||
Weight loss ≤ 1 kg | 22 | 18.8 |
Weight loss 1– ≤ 5 kg | 27 | 23.1 |
Weight gain (n = 14) | ||
Weight gain ≤ 1 kg | 6 | 5.1 |
Weight gain 1– ≤ 5 kg | 7 | 6.0 |
Weight gain > 5 kg | 1 | 0.9 |
No change between the weight measured at the last visit (n = 48) | ||
No change | 48 | 41.0 |
% total weight loss after 9–12 months follow-up (compared to initial visit) | Frequency (n) | Percentage (%) |
|---|---|---|
 0–5% | 8 | 6.8 |
 5–10% | 50 | 42.7 |
  > 10% | 53 | 45.3 |
Males (n = 32) | ||
 0–5% | 3 | 9.4 |
 5–10% | 16 | 50.0 |
  > 10% | 13 | 40.6 |
Females (n = 79) | ||
 0–5% | 5 | 5.9 |
 5–10% | 34 | 40.0 |
  > 10% | 40 | 47.1 |